Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cancer epigenetics in clinical practice
Verónica Dávalos, Manel Esteller
CA A Cancer Journal for Clinicians (2022) Vol. 73, Iss. 4, pp. 376-424
Open Access | Times Cited: 141

Showing 1-25 of 141 citing articles:

Tumor biomarkers for diagnosis, prognosis and targeted therapy
Yue Zhou, Lei Tao, Jiahao Qiu, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 126
Aging and cancer
Léa Montégut, Carlos López-Otı́n, Guido Kroemer
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 37
Protein neddylation and its role in health and diseases
Shizhen Zhang, Qing Yu, Zhijian Li, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 34
Cold and hot tumors: from molecular mechanisms to targeted therapy
Bo Wu, Bo Zhang, Bowen Li, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 30
Nanomedomics
Ganghao Liang, Wanqing Cao, Dongsheng Tang, et al.
ACS Nano (2024) Vol. 18, Iss. 17, pp. 10979-11024
Closed Access | Times Cited: 27
Cancer, metastasis, and the epigenome
Saurav Kiri, Tyrone Ryba
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 20
Epigenetic regulation in cancer therapy: From mechanisms to clinical advances
Lei Tao, Yue Zhou, Yuan Luo, et al.
MedComm – Oncology (2024) Vol. 3, Iss. 1
Open Access | Times Cited: 17
Epigenetic regulation in cancer
Minzhi Gu, Bo Ren, Yuan Fang, et al.
MedComm (2024) Vol. 5, Iss. 2
Open Access | Times Cited: 16
Hepatocellular carcinoma: signaling pathways and therapeutic advances
Jiaojiao Zheng, Siying Wang, Lei Xia, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 4
Multi-stage mechanisms of tumor metastasis and therapeutic strategies
Zaoqu Liu, Jingqi Chen, Yuqing Ren, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 12
The Epigenetic Hallmarks of Cancer
Manel Esteller, Mark A. Dawson, Cigall Kadoch, et al.
Cancer Discovery (2024) Vol. 14, Iss. 10, pp. 1783-1809
Closed Access | Times Cited: 11
Epigenomic insights into common human disease pathology
Christopher G. Bell
Cellular and Molecular Life Sciences (2024) Vol. 81, Iss. 1
Open Access | Times Cited: 9
Multimodal analysis of cfDNA methylomes for early detecting esophageal squamous cell carcinoma and precancerous lesions
Jiaqi Liu, Lijun Dai, Qiang Wang, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 9
Small-molecule-based targeted therapy in liver cancer
Ming Yue, Yanqiu Gong, Xuewen Fu, et al.
Molecular Therapy (2024) Vol. 32, Iss. 10, pp. 3260-3287
Closed Access | Times Cited: 9
Challenges and Opportunities in Developing Targeted Therapies for Triple Negative Breast Cancer
Abygail G. Chapdelaine, Gongqin Sun
Biomolecules (2023) Vol. 13, Iss. 8, pp. 1207-1207
Open Access | Times Cited: 21
Combination of epidrugs with immune checkpoint inhibitors in cancer immunotherapy: From theory to therapy
Ruoyu Guo, Jixia Li, Jinxia Hu, et al.
International Immunopharmacology (2023) Vol. 120, pp. 110417-110417
Open Access | Times Cited: 16
Regulation and clinical potential of telomerase reverse transcriptase (TERT/hTERT) in breast cancer
Ruozhu Yang, Yi Han, Xinyu Guan, et al.
Cell Communication and Signaling (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 16
Epigenetic silencing ZSCAN23 promotes pancreatic cancer growth by activating Wnt signaling
Qian Du, Meiying Zhang, Aiai Gao, et al.
Cancer Biology & Therapy (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 7
The Killer’s Web: Interconnection between Inflammation, Epigenetics and Nutrition in Cancer
Marisabel Mecca, Simona Picerno, Salvatore Cortellino
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 5, pp. 2750-2750
Open Access | Times Cited: 7
Beyond the tail: the consequence of context in histone post-translational modification and chromatin research
Ellen N Weinzapfel, Karlie N. Fedder-Semmes, Zu‐Wen Sun, et al.
Biochemical Journal (2024) Vol. 481, Iss. 4, pp. 219-244
Open Access | Times Cited: 6
The drug delivery of methimazole through the sensing function assessments of BeO fullerene-like particles: DFT study
Mounir M. Salem‐Bekhit, Miao Dai, М. М. Рахматуллаева, et al.
Chemical Physics Impact (2023) Vol. 7, pp. 100335-100335
Open Access | Times Cited: 14
Preoperative systemic immune-inflammation index as a prognostic indicator for patients with urothelial carcinoma
Jianxiong Zheng, Peng Lei, Shaohua Zhang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 13
DCAF13 inhibits the p53 signaling pathway by promoting p53 ubiquitination modification in lung adenocarcinoma
Shan Wei, Jing Xing, Jia Chen, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 5
Single-cell Multiomics Analysis of Myelodysplastic Syndromes and Clinical Response to Hypomethylating Therapy
Ignacio Campillo‐Marcos, Marta Casado-Peláez, Verónica Dávalos, et al.
Cancer Research Communications (2024) Vol. 4, Iss. 2, pp. 365-377
Open Access | Times Cited: 5
Current trends in clinical trials and the development of small molecule epigenetic inhibitors as cancer therapeutics
Nazanin Zohourian, James A. L. Brown
Epigenomics (2024) Vol. 16, Iss. 9, pp. 671-680
Closed Access | Times Cited: 5
Page 1 - Next Page

Scroll to top